Literature DB >> 2162144

Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis.

J W Karaszewski1, A T Reder, R Maselli, M Brown, B G Arnason.   

Abstract

Immune abnormalities, including deficient CD8 lymphocyte-mediated suppression, have been implicated in the progression of multiple sclerosis (MS). The peripheral sympathetic branch of the autonomic nervous system innervates the lymphoid organs and affects immune function. Animals with an ablated sympathetic nervous system develop more severe experimental allergic encephalomyelitis than control animals and exhibit an increased density of beta-adrenergic receptors on their lymphocytes. Experimental allergic encephalomyelitis shares many features with MS. Accordingly, we investigated the psychogalvanic skin reflex in patients with rapidly progressive MS and found that 13 patients (57%) lacked this sympathetic-mediated response. The density of beta-adrenergic receptors on lymphocyte subsets was increased in progressive MS, most notably on the CD8 suppressor/cytotoxic subset. B lymphocytes had the greatest number of receptors with 12.1 +/- 1.8 fmol/10(6) cells in control subjects and 18.7 +/- 2.6 fmol/10(6) cells in patients with MS. CD8 lymphocytes possessed an intermediate number of receptors with 3.4 +/- 0.4 fmol/10(6) cells in control subjects and 9.1 +/- 1.6 fmol/10(6) cells in patients with MS. CD4 lymphocytes demonstrated the fewest receptors with 1.2 +/- 0.1 fmol/10(6) cells in control subjects and 1.8 +/- 0.4 fmol/10(6) cells in patients with MS. No differences in the affinity or function (cyclic adenosine monophosphate levels in response to 10(-5) M (-)isoproterenol) of the adrenergic receptor were found when patients with progressive MS and control subjects were compared. Autonomic abnormalities in progressive MS and the increased beta-adrenergic receptor density found on CD8 lymphocytes may be related.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162144     DOI: 10.1002/ana.410270404

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

Review 1.  Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis.

Authors:  E M Frohman; N L Monson; A E Lovett-Racke; M K Racke
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

Review 2.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

3.  Acute stress reduces intraparenchymal lung natural killer cells via beta-adrenergic stimulation.

Authors:  O Kanemi; X Zhang; Y Sakamoto; M Ebina; R Nagatomi
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

Review 4.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

5.  Sympathetic vasoconstrictor responses in multiple sclerosis with thermo-regulatory dysfunction.

Authors:  E B Andersen; A M Nordenbo
Journal:  Clin Auton Res       Date:  1997-02       Impact factor: 4.435

6.  Relative quantification of beta-adrenergic receptor in peripheral blood cells using flow cytometry.

Authors:  Didem Saygin; Nicholas Wanner; Jonathan A Rose; Sathyamangla V Naga Prasad; W H Wilson Tang; Serpil Erzurum; Kewal Asosingh
Journal:  Cytometry A       Date:  2018-03-24       Impact factor: 4.355

Review 7.  End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology.

Authors:  Mirjana Dimitrijevic; Stanislava Stanojevic; Natasa Kustrimovic; Gordana Leposavic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

8.  Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study.

Authors:  Y Zoukos; T N Thomaides; D Kidd; M L Cuzner; A Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

Review 9.  Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-17       Impact factor: 4.147

10.  Abnormal sympathetic skin response in patients with autoimmune vitiligo and primary autoimmune hypothyroidism.

Authors:  M Merello; M Nogues; R Leiguarda; C López Saubidet; A Florin
Journal:  J Neurol       Date:  1993-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.